Drugmaker UCB Sues Rival Sun Over Planned Vimpat Generic
Drugmaker UCB Inc. on Thursday sued Sun Pharmaceutical Industries Ltd. in Illinois federal court, accusing its rival of infringing one of its patents with a planned generic version of epilepsy treatment...To view the full article, register now.
Already a subscriber? Click here to view full article